Nucleai
Drug Discovery · Biotechnology
Overview
Nucleai helps biopharma answer two critical questions: why does a therapy work, and which patients will benefit?
Funding and backers
Backers
3
Grove Ventures, M Ventures
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 2021
Website went live first capture in the Wayback Machine
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
SAV Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Soricimed Biopharma is a clinical stage drug development company dedicated to novel trageted treatments for cancer.
Analyst-grade AI system that answers complex questions across millions of references to optimize drug development and clinical trials.
Bridging the uncertainty divide between academic research and drug development Mission This folder does not contain any pages.
Make confident decisions about drug development, quickly and efficiently, using a decision-engine that takes your toughest translational…
Supper connects your data, cleans it, and maps your business language so you can answer critical questions in minutes.
PharosBio is building an autonomous AI scientist—a platform and APIs that help biopharma and research teams reduce R&D risk by turning…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Grove VenturesVia a fund
M VenturesVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely